Bringing District-Hospital Pharmacy
to FIP Montreal

Reaching the 80% of Taiwan's pharmacists who work outside medical centers

Tsung Wei Chang, M.S. Pharm.
Clinical Pharmacist, Yuanlin Christian Hospital
Adjunct Lecturer, Dept. of Pharmacy, Chia Nan University of Pharmacy & Sciences
June 2026

A Decade of Submissions, One Pharmacist

Where I started

Yuanlin Christian Hospital · district hospital, Changhua
B.Pharm, Dept. of Pharmacy, Chia Nan University of Pharmacy & Sciences
M.S. Clinical Pharmacy, Taipei Medical University (in-service, 2021)
Adjunct Lecturer, Dept. of Pharmacy, Chia Nan University of Pharmacy & Sciences

Where it has led

9 first-author posters / orals at FIP & FAPA since 2017
7 international peer-reviewed papers · H-2
8 articles in 藥師週刊 · 5 are FIP congress reports
28-center day-care medication safety program

From one HIV case report in Seoul 2017 — to two acceptances at Montreal 2026.
Each year, one step further.

TOPIC 1 · RESEARCHOral #353 — Background

Bridging the Gap in Geriatric Care

The pain points in adult day-care centers:

Polypharmacy 多重用藥

Elderly residents on complex regimens, high risk of ADRs and falls

Storage gaps 儲藥不當

Inadequate dedicated medication preparation space & individual cabinets

Documentation 紀錄破碎

Fragmented administration records, no standardized medication profile

🔑 No professional pharmacy oversight at the place where vulnerable elders take their medication every day.

TOPIC 1 · RESEARCHThe Tripartite Model 三方共治

We integrated three stakeholders into one standardized medication-management framework:

🏛 Health Bureau

Administrative coordination & policy enforcement

🏥 Hospital

Academic clinical support & pharmacist expertise

🏪 Community Pharmacy

Local accessibility & ongoing presence

🔑 The model's name: "One Daycare, One Pharmacist" 一日照一藥師

TOPIC 1 · RESEARCHFour-Stage Implementation

① Assessment
On-site evaluation of current practices

→

② Standardization
Unified SOPs & Medication Profile

→

③ Pilot & Iteration
3 pilot centers · iterative refinement

→

④ Scaling
3 → 28 centers (25 existing + 3 new)

🔑 Long-term goal: cover all 80 day-care centers in Changhua County.
Standardized assets: "Long-term Care Medication Profile" + "Standardized Administration Records"

TOPIC 1 · RESEARCHResults — From 44% to 100%

44% → 100%

Dedicated medication preparation space

44% → 100%

Individual storage cabinets

100%

Long-term Care Medication Profile completion

🔑 A total transition from disorganized environments to professional, pharmacy-grade storage and administration systems across all 28 centers.

📊 Live Dashboard 📹 Project Video

Project Video — 28 Day-Care Centers

TOPIC 1 · RESEARCHPoster #197 — Background

Low Investment, High Return: A Targeted Overtime Model 低投入高回報・精準加班模式

The constraint we faced:

Staffing reality

Inpatient service covered by only 3 pharmacists

Workflow problem

Routine hours dominated by dispensing — minimal time for in-depth review

🔑 We needed to decouple clinical assessment from dispensing duties — without hiring more staff.

TOPIC 1 · RESEARCHMethod — Pre/Post Comparison

Pre-Intervention (Jul–Aug 2025)

Pharmacists performed reviews during routine hours, with dispensing interruptions

Post-Intervention (Sep–Dec 2025)

Dedicated 23 hours/month overtime block for clinical review
(~7 hours/week · zero distraction)

11,537

Assessments analyzed

~91 hrs

Total overtime investment (4 months)

7 hrs / week

Average dedicated overtime

TOPIC 1 · RESEARCHResults — Disproportionate Returns

5×

Therapeutic duplication interventions
治療重複介入

3×

Medication de-escalation recommendations
用藥降階建議

85.1% → 88.0%

Physician acceptance rate
醫師接受率

🔑 ~7 hours of dedicated time per week produced disproportionate gains —
especially in time-intensive DRPs that routine workflow cannot catch.

A scalable, cost-effective solution for resource-limited district hospitals worldwide.

TOPIC 2 · FIP PLANWhat I Will Do in Montreal — Present

🎤 Short Oral #353

Deliver the talk with live dashboard demo
Engage Q&A on the "One Daycare, One Pharmacist" model
Collect specific reviewer feedback toward a journal manuscript

📋 Poster #197

Present during poster session with on-site Q&A
Network with other small-hospital pharmacists internationally
Collect reviewer input toward a parallel manuscript

🔑 Goal: Two journal manuscripts submitted within 12 months of Montreal.

TOPIC 2 · FIP PLANWhat I Will Do in Montreal — Attend

🩺 Sessions I will follow

SEC Community & Hospital Pharmacy
Workforce Development & Education
Digital Health & AI in Pharmacy
Pharmacoeconomics & HTA

❓ Questions I will ask

How are small-hospital pharmacists scaling clinical services?
What does next-generation geriatric pharmacy look like internationally?
How are FIP members using digital tools responsibly?

Hands-on past observation: at FAPA 2022 Kuala Lumpur, I walked into a Watsons community pharmacy myself, paid RM3 out of pocket, and received a glucose test from a professional pharmacist who handled only pharmaceutical services, never checkout. Citizens proactively consulted — a workflow Taiwan can learn from.

🔑 I attend FIP not to observe, but to find what answers our small-hospital pharmacists' questions back home.

TOPIC 3 · ENGAGEMENTCongress Year (2026) — Deliverables

When	What	Channel
During congress (Aug 30 – Sep 2)	3–4 dispatch articles + interview with a FIP leader	藥師週刊
During congress	15+ social posts & live observations	慢慢來藥師 (FB 8,896 / IG / Blog)
Post-congress (Sep)	Full post-congress report	TSHP newsletter
Post-congress (Oct–Nov)	One oral sharing & Q&A	TSHP bimonthly meeting
Post-congress (Dec)	Year-end international affairs summary	慢慢來藥師 + Telegram channel

🔑 I have written FIP dispatches for 藥師週刊 for three years already.
With TSHP's support, I will do this for the society first.

藥師週刊: #2331 Brisbane · #2378 Cape Town · #2427 Sinclair · #2427 Reception
慢慢來藥師 (Copenhagen 2025 series): Rigshospitalet 醫院藥局 · Kongelig Hof Apotek 社區藥局

TOPIC 3 · ENGAGEMENTYear 2 (2027) — Deliverables

📝 Research output

2 journal manuscripts derived from #353 / #197
Reviewer-feedback-driven refinements built in

🎓 Teaching

2 TSHP-credited lectures on intl engagement
Integrate FIP content into Chia Nan curriculum

🌐 Speaker network · 🤝 Collaboration

Source 3+ international speakers for TSHP events
Co-organise 1 Taiwan-hosted intl workshop
Report at Intl Affairs Committee annual review

Already done: panelist on Taiwan & Overseas Pharmacy Forum EP13 (FAPA experience, UMN-hosted)

TOPIC 3 · DIRECTIONWhy I Am Asking This Year

2017-01-24 · My first email to a stranger

His reply · A hand-drawn study-design tree from a stranger I still cannot identify

In 2017 I emailed a stranger pharmacist, asking how to submit my first FIP abstract. He replied: "I've never submitted to FIP myself, but..." — and drew this tree by hand. That email led to my first FIP poster in Seoul.

🔑 Today I want to be the one who replies — for the 80% of Taiwan's pharmacists who work outside medical centers and rarely see what FIP discusses.
換我來當那個回信的人，給看不到 FIP 的 80% 同行

Before I close, the most personal slide. In January 2017, I emailed a complete stranger — a pharmacist whose blog I found by chance — asking how to submit my first FIP abstract. He replied honestly: he had never submitted to FIP himself. But he still drew this study-design tree by hand and encouraged my topic — caspofungin in PJP. That email led directly to my first FIP poster in Seoul later that year. Nine years on, I still do not know who that pharmacist was. I have told this story at many speaking events. The gratitude has stayed. That is why I am asking this year. Most of Taiwan's pharmacists do not work in medical centers — they work in district hospitals, community settings, day-care centers, like me. Today I want to be the one who replies — for the 80% of pharmacists who otherwise rarely see what FIP discusses. With TSHP's support, I can do this work for the society's own channels. I am asking not because Montreal is special, but because the work has matured to a point where TSHP's support can multiply its reach.

Thank You for Walking This Next Step With Me

Ten years ago, presenting a single case report in Seoul,
I could not have imagined sitting here today.

If given this opportunity, I will represent TSHP with care,
and bring back what I learn for our community.

Thank you — I welcome your questions and your guidance.